Several residues of the human neurokinin-2 receptor have been identifi
ed to be critical for the binding of peptide agonists and non-peptide
antagonists. Amino acid substitutions in the first and second extracel
lular segments and the second transmembrane segment led to substantial
reduction in peptide affinity without affecting the affinity of antag
onist SR48968. These effects are identical to those observed for homol
ogous residues in the neurokinin-l receptor, suggesting that these thr
ee regions are involved in high-affinity peptide binding to both recep
tor subtypes. On the other hand, some conserved residues in the fourth
to seventh transmembrane segments are required for peptide binding to
only one receptor subtype but not both. The conserved nature and loca
tion of these receptor residues suggest that the distance between boun
d peptide and helices 4-7 varies depending on the receptor subtype. It
is likely that the conformational compatibility between a ligand and
a given receptor determines the magnitude of binding affinity, and thu
s receptor subtype selectivity. While many single-residue substitution
s did not affect the binding affinity of the antagonist SR48968, two d
ouble mutants in the sixth and seventh transmembrane segments were fou
nd to reduce its affinity substantially. Therefore, receptor residues
participate cooperatively in the binding of SR48968. These results dem
onstrate the usefulness of combining single-residue substitutions in s
tudying and confirming the role of receptor residues in ligand binding
. Finally, the overlapping nature of agonist and antagonist binding si
tes is consistent with the observation that substitutions of some resi
dues modify the binding affinities of both peptide agonists and non-pe
ptide antagonists.